Employee Stock Plans (Tables)
|
9 Months Ended |
Oct. 31, 2022 |
Share-Based Payment Arrangement [Abstract] |
|
Schedule of Stock Option Activity |
The following tables summarize stock option activity and related information (in thousands, except weighted-average exercise price, weighted-average grant date fair value and average remaining contractual term): | | | | | | | | | | | | | | | | | | | | | | | | | Shares Subject To Outstanding Stock Options | | Weighted-Average Exercise Price | | Average Remaining Contractual Term (Years) | | Aggregate Intrinsic Value | Balance, January 31, 2022 | 8,560 | | | $ | 9.22 | | | 5.9 | | $ | 67,259 | | Granted | 20 | | | 12.52 | | | | | | Exercised | (398) | | | 5.23 | | | | | | Forfeited | (307) | | | 14.21 | | | | | | Balance, October 31, 2022 | 7,875 | | | 9.23 | | | 5.2 | | 14,046 | | Exercisable as of October 31, 2022 | 3,274 | | | 3.40 | | | 2.7 | | 14,046 | | Vested and expected to vest as of October 31, 2022 | 7,743 | | | 9.15 | | | 5.2 | | 14,046 | |
|
Schedule of Stock Option Grant Date Fair Value and Intrinsic Value of Options Exercised |
| | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended October 31, | | Nine Months Ended October 31, | | 20221 | | 20211 | | 2022 | | 2021 | | | | | | | | | Weighted-average grant date fair value per share of options granted during each respective period | — | | — | | $ | 5.54 | | | $ | 6.54 | | Aggregate intrinsic value of options exercised during each respective period | $ | 356 | | | $ | 12,868 | | | $ | 2,386 | | | $ | 27,606 | |
_________________________________ (1) No stock options were granted during the three months ended October 31, 2022 and 2021.
|
Schedule of Valuation Assumptions for Estimated Fair Value of Stock Options |
We used the Black-Scholes option-pricing model to estimate the fair value of our stock options granted during each respective period using the following assumptions1: | | | | | | | | | | | | | | | | | | | Nine Months Ended October 31, | | | | | | 2022 | | 2021 | Fair value of common stock | | | | | $ | 12.52 | | | $15.64 - $15.87 | Expected volatility | | | | | 42.6 | % | | 42.3% - 42.7% | Expected term (years) | | | | | 5.8 | | 6.0 - 6.1 | Risk-free interest rate | | | | | 3.0 | % | | 1.0%- 1.1% | Expected dividend yield | | | | | — | % | | — | % |
______________ (1) No stock options were granted during the three months ended October 31, 2022 and 2021.
|
Schedule of RSU Activity |
The following table summarizes RSU activity and related information (in thousands, except weighted-average grant date fair value): | | | | | | | | | | | | | Number of RSUs Outstanding | | Weighted-Average Grant Date Fair Value | Balance, January 31, 2022 | 12,171 | | | $ | 15.46 | | Granted | 8,566 | | | 11.93 | | Vested | (4,418) | | | 15.14 | | Forfeited | (2,085) | | | 14.24 | | Balance, October 31, 2022 | 14,234 | | | 13.62 | |
|
Schedule of PSU Activity |
The following table summarizes PSU activity and related information (in thousands, except weighted-average grant date fair value): | | | | | | | | | | | | | Number of PSUs Outstanding | | Weighted-Average Grant Date Fair Value | Balance, January 31, 2022 | — | | | $ | — | | Granted | 2,905 | | | 15.21 | | Vested | — | | | — | | Forfeited | — | | | — | | Balance, October 31, 2022 | 2,905 | | | $ | 15.21 | |
|
Schedule of Valuation Assumptions for Estimated Fair Value of ESPP |
We estimated the fair value of ESPP purchase rights using a Black-Scholes option pricing model with the following assumptions: | | | | | | | | | | | | | Nine Months Ended October 31, | | 2022 | | 2021 | Fair value of common stock | $ | 8.91 | | | $ | 16.07 | | Expected volatility | 44.4% - 52.3% | | 41.8% - 53.2% | Expected term (years) | 0.5 - 2.0 | | 0.5 - 2.0 | Risk-free interest rate | 2.3% - 3.2% | | 0.1% - 0.2% | Expected dividend yield | — | % | | — | % |
|
Schedule of Stock-Based Compensation Expense |
Stock-based compensation expense was recorded in the following cost and expense categories in the accompanying unaudited condensed consolidated statements of comprehensive loss (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended October 31, | | Nine Months Ended October 31, | | 2022 | | 2021 | | 2022 | | 2021 | Cost of subscription revenue | $ | 2,437 | | | $ | 1,580 | | | $ | 6,517 | | | $ | 4,157 | | Cost of professional services revenue | 3,479 | | | 2,822 | | | 10,186 | | | 7,487 | | Research and development | 7,536 | | | 5,774 | | | 20,967 | | | 15,546 | | Sales and marketing | 10,188 | | | 6,298 | | | 27,603 | | | 15,993 | | General and administrative | 5,367 | | | 3,438 | | | 14,772 | | | 8,595 | | Total stock-based compensation expense | $ | 29,007 | | | $ | 19,912 | | | $ | 80,045 | | | $ | 51,778 | |
|
Schedule of Unrecognized Compensation Costs Related to Unvested Equity Awards |
As of October 31, 2022, unrecognized compensation costs related to unvested equity awards and the weighted-average remaining period over which those costs are expected to be recognized were as follows (dollars in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | Stock Options | | RSUs | | PSUs | | ESPP | Unrecognized compensation costs | $ | 6,766 | | | $ | 159,074 | | | $ | 10,028 | | | $ | 7,748 | | Weighted-average remaining recognition period | 1.8 years | | 2.3 years | | 1.8 years | | 1.1 years |
|